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ABSTRACT 
 
Aim: To determine peripheral blood neutrophil superoxide release and C-reactive protein 
(CRP) concentration in chronic periodontitis patients, before and after non-surgical 
periodontal treatment. 
 
Materials & Methods: Neutrophils were isolated from patient and control volunteers (n=20) 
and superoxide measured by lucigenin-enhanced chemiluminescence with and without 
stimulation with unopsonised P. gingivalis, unopsonised F. nucleatum and phorbol 12-
myristate 13-acetate (PMA) before and 2-months following non-surgical therapy. 
Corresponding high-sensitivity plasma CRP concentrations were also determined. 
 
Results: At pre-treatment baseline, patient neutrophils released more superoxide in the 
absence (P<0.032) and presence of periodontal bacteria (P<0.013) and after PMA stimulation 
(P=0.041) compared to control cells. Post-therapy, patient neutrophil superoxide release was 
reduced to control cell levels. Median patient plasma CRP concentrations were non-
significantly higher than control values and were reduced after therapy (1.80mg/l to 
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1.36mg/l). Patient pre-treatment baseline, unstimulated neutrophil superoxide release showed 
a significant positive correlation with plasma CRP concentration (P=0.01). 
 
Conclusions: Chronic periodontitis is characterised by peripheral neutrophils exhibiting 
superoxide hyperactivity and hyper-reactivity to periodontal pathogens that is not a 
constitutive feature of periodontitis patients. The positive, pre-therapy relationship between 
unstimulated neutrophil superoxide release and plasma CRP is consistent with a protective 
role for CRP in reducing oxidative stress and systemic inflammation in vivo. 
 
Clinical Relevance 
Scientific rationale for the study: The pathogenesis of chronic periodontitis is characterised 
by a dysregulated neutrophilic inflammatory-immune response and greater concentrations of 
systemic inflammatory markers. These are important in relation to the potential for collateral 
host tissue damage and also an increased risk of systemic co-morbidity. 
 
Principal findings: Neutrophils from patients with chronic periodontitis released 
significantly more superoxide in the absence and presence of periodontal pathogens, which 
was corrected by successful non-surgical treatment. 
Practical implications: Periodontal treatment may help to normalise systemic neutrophil 
oxidative/inflammatory activity and reduce the risk of periodontitis-associated co-morbidity.  
Conflict of Interest and Source of Funding: 
The authors declare that they have no conflict of interests arising from this work. This work 
was supported by the Birmingham and the Black Country Comprehensive Local Research 
Network (NIHR UKCRN Study ID no. 10318) and the University of Birmingham (Sponsor 
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INTRODUCTION 
Chronic periodontitis is a prevalent inflammatory disease resulting from a dysregulated host 
response to the plaque biofilm that forms on tooth surfaces in the absence of adequate oral 
hygiene (Van Dyke 2008). The disease is characterised by neutrophil hyperactivity/-reactivity 
in terms of the generation of reactive oxygen species (ROS) and raised levels of systemic 
inflammatory markers, such as C-reactive protein (CRP; Paraskevas et al. 2008). While the 
former is thought to be responsible for collateral host tissue damage (reviewed by Chapple 
and Matthews 2007), recent studies have suggested that physiological levels of CRP may 
generally reduce neutrophil ROS generation (Ling et al. 2014). 
There have been a variety of reports demonstrating neutrophil ROS hyper-reactivity 
in untreated chronic periodontitis, however, in terms of physiologically relevant stimuli, these 
by Chapple and Matthews 2007). Two studies have investigated neutrophil responses to 
unopsonised F. nucleatum and demonstrated hyper-reactivity in terms of extracellular 
neutrophil ROS release in untreated chronic periodontitis patients (Matthews et al. 2007a, 
Dias et al. 2013). One of these studies also demonstrated that patient neutrophils released 
exaggerated amounts of ROS in the absence of overt stimulation (i.e. hyperactivity; Matthews 
et al. 2007a). 
Neutrophils isolated from treated chronic periodontitis patients have similarly been 
reported to exhibit luminol- -stimulated ROS hyper-reactivity 
suggesting that this aberrant response is constitutional rather than reactive (Fredriksson et al. 
2003, Gustafsson et al. 2006). However, no objective clinical data supporting the presence of 
periodontal health was provided.  By contrast, the only longitudinal intervention study 
investigating the impact of clinically verified, successful therapy demonstrated loss of 
luminol-detect -stimulated ROS hyper-reactivity but retention of 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
hyperactivity in respect of unstimulated isoluminol-detectable (extracellular) ROS release 
(Matthews et al. 2007b). Current data are therefore unclear in relation to the effect of 
successful periodontal therapy on unstimulated and stimulated neutrophil ROS generation. 
Furthermore, there are currently no longitudinal intervention studies performed following 
stimulation with periodontal pathogens.  
Recently, it has been shown that physiologically-relevant concentrations of CRP 
significantly influence neutrophil ROS generation and release in the absence and presence of 
F. nucleatum (Ling et al. 2014). This has important implications since 
it is recognised that plasma CRP levels are elevated in patients with untreated chronic 
periodontitis (Paraskevas et al. 2008, Li et al. 2014). Although several studies report FcγR-
stimulated ROS hyper-reactivity and higher CRP concentrations in patients compared to 
controls, no attempt has been made to relate these two parameters (Fredriksson et al. 1998, 
1999, 2003, Gustafsson et al. 2006).  
 The aim of this current study was to determine neutrophil superoxide release from 
patients with chronic periodontitis, in the absence and presence of stimulation with 
unopsonised periodontal pathogens, before and 2 months after clinically verified, successful 
non-surgical periodontal therapy. In addition, high sensitivity plasma CRP concentrations 
were measured before and after therapy to determine any relationship with neutrophil 
superoxide release.   
MATERIALS & METHODS  
Ethical approval, study populations and clinical measures of disease in patients before and 
after therapy 
Ethical approval was granted by the West Midlands Research Ethics Committee (ref. 
10/H1208/48) and the Birmingham Community Healthcare NHS Trust.  The study was 
adopted onto the National Institute of Health Research Network Portfolio (Study ID 10318) 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
and registered on ClinicalTrials.gov (Identifier NCT01233765). The study cohorts consisted 
of volunteers diagnosed with chronic periodontitis (n=20; 12 male and 8 female; mean age = 
46+8 yrs, range 37-61 yrs) along with age- and gender-matched periodontally and 
systemically healthy control volunteers (n=20; 12 male, 8 female; mean age = 46+8 yrs, 
range 32-62 yrs). The sample size was based upon our previous published studies of 
neutrophil ROS responses (Matthews et al. 2007a, 2007b) where, using 18-19 volunteer pairs, 
significant differences in unstimulated, extracellular, isoluminol-detectable ROS release were 
detected between patient and control cells.  Analysis of these published data showed that 18-
20 patient-control pairs were required for a test of equality at the 0.05 level of significance 
with 80% power. All volunteers were never-smokers and systemically healthy as confirmed 
by a detailed medical history questionnaire. Chronic periodontitis was defined as the presence 
of at least two non-adjacent sites with probing pocket depths >4mm, along with radiographic 
bone loss >30% of the root length (non-first molar or incisor sites) in accordance with the 
consensus criteria of the European Federation of Periodontology (Tonetti et al. 2005).  All 
clinical measures of periodontal disease (probing pocket depth, bleeding on probing, gingival 
and plaque indices) were significantly greater in the patient compared to control volunteer 
cohort (P<0.001). Patient volunteers received tailored oral hygiene instruction and 
conventional non-surgical periodontal therapy by a single operator. This consisted of scaling 
and root surface debridement of all periodontal pockets >4mm performed under local 
anaesthesia on a quadrant-by-quadrant basis within a maximum of 4 weeks. All clinical 
measures of disease were significantly reduced at the 2-month post-periodontal treatment 
review (P<0.05), with patient levels becoming comparable to those of healthy controls (Ling 
et al. 2015). 
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Collection of peripheral blood samples and isolation of neutrophils 
Peripheral blood was obtained from paired volunteers with chronic periodontitis and age-
/gender-matched controls before (baseline; n=20) and 2 months after conventional non-
surgical periodontal therapy (review; n=19). Blood was obtained between 09:00 and 10:00 
am from a patient and a matched healthy control volunteer within 30 min of each other. 
Blood was collected from the antecubital fossa into Vacutainers
TM
 (Greiner, Bio-One Ltd, 
Stonehouse, UK; 6ml) containing lithium heparin (17 IU/ml) as an anticoagulant. Peripheral 
blood neutrophils were isolated using a discontinuous Percoll gradient (δ = 1.079:1.098), 
followed by erythrocyte lysis as previously described (Ling et al. 2014, 2015).  
 
Determination of plasma CRP concentration 
Vacutainers
TM
 were centrifuged in sealed buckets at 1,000 RCF for 30 mins at 4
o
C and the 
separated plasma removed, aliquoted into cryogenic vials (0.5 ml/vial) and stored at -80
o
C. 
High-sensitivity CRP (hsCRP) analyses were subsequently performed by the UK National 
Protein Reference Centre, Immunology Department and Protein Reference Unit, Sheffield 
Teaching Hospitals NHS Foundation Trust. Laboratory analyses of plasma CRP 
concentration were performed blinded to the origin of the samples. 
 
Preparation of stimuli 
Fusobacterium nucleatum (Fn; ATCC 10953) and Porphyromonas gingivalis (Pg; ATCC 
33277) were grown anaerobically at 37 
o
C as previously described (Roberts et al. 2002). 
Bacteria were washed 3 times in sterile PBS and heat-treated (100 
o
C for 10 min) prior to 
dilution with sterile PBS to give a final suspension of 8.5 x 10
9
 bacteria/ml and 4.1 x 10
9
 
bacteria/ml for F. nucleatum and P. gingivalis respectively, and stored at -80 
o
C. Phorbol 12-
myristate 13-acetate (PMA; P8139; Sigma-Aldrich Ltd, Gillingham, Dorset, UK) was 
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reconstituted with DMSO to give a 1 mg/ml (1.62 mM) stock solution that was stored at -20 
o
C. Working suspensions/solutions of all stimuli were prepared by diluting stock solutions 
with PBS immediately prior to use to give a multiplicity of infection (MOI) of 100:1 for 
bacteria and a final concentration of 5 nM for PMA. 
 
Preparation of lucigenin 
A 1 mg/ml stock solution of lucigenin (N.N’-Dimethyl-9,9’biacridium dinitrate; M8010; 
Sigma-Aldrich Ltd, Gillingham, Dorset, UK) in PBS was prepared and stored at 4 
o
C. A 0.33 
mg/ml working solution was prepared by diluting this stock 1:3 with PBS. 
 
Lucigenin-enhanced chemiluminescence assay to measure extracellular superoxide anion 
radical production 
Twenty µl of glucose-supplemented PBS (PBS containing 1 mM glucose, 1.5 mM CaCl2 and 
1 M MgCl2; GPBS), 25 µl of PBS and 30 µl lucigenin (0.33 mg/ml; specific for detecting 
extracellular superoxide release; Dahlgren et al. 1985) were added to pre-blocked (PBS 
containing 1 % BSA, overnight, 4 
o
C) white microwells (Microlite 2, VWR, Lutterworth, 
UK). Following the addition of reagents, 100 µl of neutrophil cell suspension (1 x 10
6
 
cells/ml in GPBS; 1 x 10
5
 cells) were then added to each well and the plate immediately 
transferred to the plate reader and light output recorded for 1 s per well in relative light units 
(Berthold microplate luminometer LB96v, Berthold Technologies UK Ltd) at 37 
o
C. Baseline 
light output was recorded for 30 mins before addition of stimuli or vehicle control (PBS; 25 
µl), giving a total volume of 200 µl per well. Light output as then recorded for a further 120 
mins. All samples were analysed in quadruplicate, with paired patient and control cells 
isolated and analysed at the same time, maintaining the specific patient/control pairing both 
pre- and post-treatment. Peak relative light units (RLU) were used for assessment of 
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chemiluminescence kinetics, as this is considered a reliable parameter (Allen 1986) and 
corresponds with the area under the chemiluminescence curve (Allen 1986, Hasegawa et al. 
1997). All laboratory lucigenin-enhanced chemiluminescence analyses were performed 
blinded to the origin of the samples. 
 
Data handling and statistical analyses 
Data were recorded and manipulated in Microsoft Excel and evaluated using GraphPad Prism 
5 (version 5.04; GraphPad Software, La Jolla, CA, USA). Data distribution was determined 
using the Kolmogorov-Smirnov test. Differences in probing pocket depths, the only dataset 
found to be normally distributed, were determined by ANOVA followed by Tukey-Kramer 
multiple comparisons test. All other statistical comparisons were performed using non-
parametric methods, as indicated in the text and/or Table/Figures. Detection of ROS by 
chemiluminescence methods can show considerable day-to-day variation making the 
inclusion of a paired, age and gender matched control, whose neutrophils are analysed 
simultaneously with those from the patient, important if consistent and comparable results are 
to be obtained (Yaffe et al. 1999). Data derived from such experiments are thus normally 
analysed using paired statistical analyses to determine the presence of neutrophil hyper-
reactivity (Fredriksson et al. 1998, 1999, 2003, Matthews et al. 2007a, 2007b), namely 
Wilcoxon rank sum and Friedman followed by Dunn’s multiple comparisons tests as outlined 
within the figure legends. Plasma hsCRP concentrations were compared using Mann-
Whitney U test.  
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RESULTS 
Longitudinal changes in clinical measures 
Non-surgical periodontal therapy resulted in improvements in all clinical measures of the 
disease at the 2-month post-treatment review with the percentage of sites exhibiting bleeding 
on probing and gingival and plaque indices being reduced to healthy control levels (Table 1).  
 
Neutrophil superoxide release in the absence and presence of stimulation 
Patient neutrophils released significantly more unstimulated superoxide compared to controls 
at baseline pre-treatment (P=0.005; Figure 1). After stimulation with P. gingivalis, F. 
nucleatum and PMA, both patient and control neutrophils released significantly greater 
amounts of superoxide compared with PBS vehicle control (P<0.05) and the amount of 
superoxide release differed significantly between stimuli (P<0.0001). Although there were no 
significant differences between P. gingivalis and F. nucleatum stimulated superoxide release, 
PMA stimulated approximately 3-6 times more superoxide compared to bacterial stimuli 
(P<0.001). Overall, patient neutrophils released significantly more superoxide compared to 
controls when comparing the combined data for all stimuli (P=0.0001) and data for 
individual stimuli, including PBS (vehicle control) (Figure 1). 
 At the 2-month post-treatment review, there were no significant differences in 
unstimulated superoxide release between patient and control neutrophils (Figure 1). However, 
in agreement with the pre-treatment data, neutrophils released significantly more superoxide 
after stimulation (P<0.05), with PMA eliciting a significantly higher chemiluminescence 
response compared to bacterial stimuli (P<0.01). Overall, there were no significant 
differences in stimulated superoxide release between patients and control neutrophils when 
comparing the combined data for all stimuli (P=0.26) or when analysing data for the 
individual stimuli (Figure 1).  
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 As a percentage of paired control, there was a significant reduction in patient 
superoxide release at review compared to baseline for PBS treated cells (P=0.004; vehicle 
control), P. gingivalis (P=0.004) and F. nucleatum (P=0.0007) stimulated cells (Figure 2). 
There were no significant changes in unstimulated or PMA stimulated superoxide levels 
between baseline and review, although median levels of both were lower post-therapy.  
 
Plasma hsCRP and relationship with neutrophil superoxide release 
There was considerable variation in plasma hsCRP concentration within both patient and 
control groups at baseline and review (Figure 3). Although the median patient hsCRP 
concentration (1.80mg/l) was higher than that of controls (0.95mg/l), and decreased following 
periodontal treatment (1.36mg/l, patient; 0.91mg/l, control), the differences were not 
statistically significant.  
Regression analyses of unstimulated superoxide release and plasma CRP 
concentration demonstrated a moderate, significant positive correlation for patients at 
baseline (P=0.01; Figure 4), which was not found at post-therapy review.  No such 
relationship was detected for the control group or when stimulated superoxide levels were 
investigated. 
 
DISCUSSION 
This is the first study to determine neutrophil superoxide release in a longitudinal 
intervention study designed to assess the effect of successful periodontal therapy on 
peripheral blood neutrophil hyperactivity (increased superoxide release in the absence of 
stimulation) and hyper–reactivity after stimulation with unopsonised periodontal pathogens. 
The data demonstrate that neutrophils from chronic periodontitis patients exhibit both 
hyperactivity, as well as hyper-reactivity to unopsonised F. nucleatum and P. gingivalis, both 
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of which can be reduced or removed after successful non-surgical periodontal therapy.   
These findings suggest that the hyperactive/-reactive neutrophil superoxide release is 
secondary to inflammation rather than being a constitutional feature of periodontitis patients.  
  Hyper- -stimulation is a well 
characterised pathological feature of chronic periodontitis (reviewed by Chapple and 
Matthews 2007). By contrast, hyper-reactivity to unopsonised periodontal pathogens is 
limited to our previous reports investigating F. nucleatum (Matthews et al. 2007a, Dias et al. 
2013) and baseline unstimulated hyperactivity has only been described in terms of increased 
isoluminol-detectable ROS (detecting HOCl derived from extracellular release of both 
superoxide and hydrogen peroxide; (Matthews et al. 2007a, 2007b). The lucigenin-based data 
presented here is specific for extracellular superoxide release, and confirm and extend these 
reports and support the conclusion that neutrophils in chronic periodontitis release excessive 
superoxide in the absence and presence of unopsonised F. nucleatum and P. gingivalis.  The 
molecular basis for this increased ROS generation has been suggested to be due to impaired 
activity of the antioxidant regulator nuclear factor erythroid-2-related factor 2 (Nrf2) in 
periodontitis neutrophils resulting in activation of the redox sensitive enzyme acid 
sphingomyelinase, with subsequent lipid raft formation and translocation of increased 
NADPH oxidase to the outer cell membrane (Dias et al. 2013).  
The effect of periodontal treatment was determined in order to elucidate whether the 
exaggerated neutrophil ROS release in chronic periodontitis was secondary to the 
inflammatory reaction within the periodontal tissues during periodontal disease or the result 
of constitutive differences between periodontitis patients and controls.  The only previous 
longitudinal intervention study suggested that unstimulated neutrophil extracellular ROS 
(isoluminol-detectable) release was constitutional but that FcγR-stimulated, luminol-
detectable intracellular ROS was probably reactive in nature, being partially reduced 
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following periodontal treatment and completely removed in the presence of priming doses of 
P. gingivalis and F. nucleatum (combined MOI = 2.25:1; Matthews et al. 2007b).  However, 
data for FcγR-stimulated extracellular, isoluminol-detectable ROS generation was equivocal, 
suggesting that hyper-reactivity was unaffected by therapy but not detectable if neutrophils 
were primed with P. gingivalis and F. nucleatum. Our current data support a reactive basis 
for exaggerated superoxide release by both unstimulated patient neutrophils and those 
stimulated with unopsonised F. nucleatum and P. gingivalis. The discrepancy between these 
two studies in terms of the effect of therapy on ROS release might relate to the specificity of 
the chemiluminescence substrates and methods employed. Lucigenin is relatively specific for 
superoxide whereas isoluminol, used in the presence of horseradish peroxidase, primarily 
detects HOCl, which is enzymatically generated from extracellular hydrogen peroxide that 
may be derived from dismutation of released superoxide as well as efflux of hydrogen 
peroxide from the cell. 
This study was limited to chronic periodontitis, which is the most prevalent form of 
periodontitis.  In terms of ROS generation by unstimulated neutrophils from patients with 
aggressive disease, studies have reported higher (Gainet et al. 1998, 1999 using DCFH-
DA/flow cytometry; Guentsch et al. 2009 using luminol; Iwata et al. 2009 using cytochrome 
c reduction), lower (Shipara et al. 1991 using cytochrome c reduction) and similar (Shapira et 
al. 1994 using cytochrome c reduction; Guentsch et al. 2009 using isoluminol) levels 
compared to those from control cells.  Data from these papers on stimulated ROS generation 
are similarly complex with four suggesting hyper-reactivity, to histone opsonised bacteria 
(Shipara et al. 1994) or fMLP (Gainet et al. 1998, 1999; Iwata et al. 2009), and one showing 
hypo-reactivity to P. gingivalis and A. actinomycetemcomitans using luminol (predominantly 
intracellular ROS) but normal reactivity with isoluminol (extracellular ROS; Guentsch et al. 
2009).  Interestingly, neutrophils from patients with aggressive disease that were primed with 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
IL-8 were hypo-reactive to fMLP (Gainet et al. 1999) whereas another study suggested that 
priming with P. gingivalis LPS was required for fMLP hyper-reactivity (Shapira et al. 1994). 
However, only Gainet and co-workers have investigated the effect of periodontal treatment, 
the success of which was not substantiated. Both studies indicated that unstimulated 
intracellular ROS hyperactivity was normalised post-treatment (Gainet et al. 1998, 1999).  
However, the effect of treatment on the hyper-reactivity of neutrophils from aggressive 
periodontitis patients to fMLP was not assessed but pre-treatment hypo-reactivity of IL-8-
primed cells to fMLP was normalised (i.e. not detected post-therapy; Gainet et al. 1999).  
These data suggest that intracellular ROS generation in aggressive periodontitis may be 
“acquired/secondary” to the disease process rather than being “constitutive”, in agreement 
with the data presented on extracellular release of superoxide in chronic periodontitis 
reported in this study, as well as those reported for intracellular, luminol-detectable ROS in 
chronic disease (Matthews et al. 2007b).  
Interestingly, the therapy-related removal of the exaggerated superoxide release 
presented here contrasts with persistence of neutrophil cytokine (IL-8, TNFα, IL-1β) hyper-
reactivity in response to F. nucleatum and P. gingivalis, recently demonstrated within this 
same volunteer cohort (Ling et al. 2015). Taken together, these data suggest that both reactive 
and constitutional mechanisms underpin the hyperactive/-reactive neutrophil phenotype in 
chronic periodontitis or that “normalisation” of excessive neutrophil cytokine production may 
take longer to correct than that of superoxide release. 
  Although there were no significant differences in plasma CRP levels between 
patients and controls or between sampling visits in this study, median levels were lower post- 
compared to pre-therapy in patients (1.80 & 1.36mg/l).  In view of this apparent change, and 
because it has been shown that physiologically-relevant concentrations of CRP (1-10mg/l) 
-stimulated superoxide release from healthy volunteer 
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neutrophils but increase their response to F. nucleatum (Ling et al. 2014), the relationship 
between superoxide release and CRP concentration was investigated.  Surprisingly, analysis 
of the current data demonstrated a significant, moderate positive correlation between 
unstimulated superoxide release and plasma CRP concentrations in untreated patients that 
was not found post-therapy.  This apparent contradiction in the data is explained by the fact 
that, in the present study, superoxide assays were performed on isolated and washed 
neutrophils in the absence of endogenous CRP.  Thus, while the pre-treatment, positive 
relationship between unstimulated superoxide release and CRP is only a cross-sectional 
observation, its loss post-therapy is consistent with neutrophil superoxide “hyperactivity” 
actually having a reactive basis rather than being constitutional. In the light of recent studies 
demonstrating that physiologically relevant concentrations of CRP (1-10mg/l) reduce 
unstimulated intra- and extra-cellular ROS production by peripheral neutrophils (Ling et al. 
2014), these data are also consistent with the concept that the increased plasma CRP seen in 
chronic periodontitis (reviewed by Paraskevas et al. 2008) may reduce peripheral blood 
neutrophil hyperactivity and offer a degree of host protection from systemic neutrophil-
associated ROS release and oxidative stress in vivo.  
In summary, these data demonstrate that peripheral blood neutrophils from untreated 
chronic periodontitis patients release excessive amounts of superoxide in the absence and 
presence of stimulation with unopsonised F. nucleatum and P. gingivalis.  Successful therapy 
removed this exaggerated superoxide response suggesting that hyperactivity/-reactivity was 
not a constitutional feature of chronic periodontitis patients but secondary to periodontal 
inflammation. In addition, the positive relationship between unstimulated neutrophil 
superoxide release and plasma CRP, detected pre-therapy, is consistent with a protective role 
for CRP in reducing oxidative stress in vivo. 
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TABLE LEGEND 
 
Table 1: Clinical measures of chronic periodontitis patients and matched healthy 
controls.   One patient (no. 13) elected to discontinue participation in the study during the 
treatment phase. Probing pocket depths were compared by one-way ANOVA followed by 
Tukey-Kramer test. All other comparisons were performed using Kruskal-Wallis test 
followed by Dunn’s test. Clinical data for these volunteer cohorts have been published 
previously (Ling et al. 2015).  
 
* 
comparison with controls 
#
 comparison with chronic periodontitis before treatment 
$
 comparison with chronic periodontitis after treatment; ns = not significant (P>0.05) 
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Table 1: Clinical measures of chronic periodontitis patients and matched healthy controls.   One patient (no. 13) elected to discontinue 
participation in the study during the treatment phase. Probing pocket depths were compared by one-way ANOVA followed by Tukey-Kramer 
test. All other comparisons were performed using Kruskal-Wallis test followed by Dunn’s test. Clinical data for these volunteer cohorts have 
been published previously (Ling et al. 2015).  
Clinical measure 
Chronic periodontitis patients Controls  
Baseline 
 (n=20) 
2 month 
Review (n=19) 
Baseline 
(n=20) 
Probing pocket depth 
(mm; mean + SD) 
3.0+0.8 (P<0.001)* 2.1+0.5 (P<0.001)
#
 
1.5+0.4 
(P<0.01)
$
 
Number of probing pocket depths >4 mm 
(median; range) 
27 (5-91) (P<0.001)* 7 (0-52) (P<0.05)
#
 
0 (0-4) 
(P<0.01)
$
 
Percentage of sites bleeding on probing 
(median; range) 
43 (16-87) (P<0.001)* 14 (3-35) (P<0.001)
#
 
2 (0-39) 
(ns)
$
 
Gingival index 
(median; range) 
2 (1-3) (P<0.001)* 1 (0-1) (P<0.001)
#
 
1 (0-1) 
(ns)
$
 
Plaque index 
(median; range) 
2 (1-3) (P<0.001)* 1 (0-2) (P<0.001)
#
 
1 (0-2) 
(ns)
$
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* 
comparison with controls 
 
#
 comparison with chronic periodontitis before treatment 
 
$
 comparison with chronic periodontitis after treatment; ns = not significant (P>0.05) 
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FIGURE LEGENDS: 
 
Figure 1: Lucigenin detectable superoxide (peak RLU) released by neutrophils from patient 
and healthy controls at baseline (n=20) and the 2-month review (n=19) without stimulation 
and in the presence of additional PBS (vehicle control), P. gingivalis (MOI 100:1), F. 
nucleatum (MOI 100:1) or PMA (5nM). Box and whisker plots show median, interquartile 
range, maximum and minimum peak RLU. P-values calculated using one-tailed Wilcoxon. 
Stimulated levels of superoxide were significantly greater than those for PBS vehicle control 
for all stimuli, at baseline and review, for both patient and control groups (P<0.05; Friedman 
followed by Dunn’s multiple comparisons test).  
 
Figure 2: Effect of periodontal treatment on unstimulated and stimulated superoxide release 
from patient neutrophils (n=19) without stimulation and in the presence of additional PBS 
(vehicle control), P. gingivalis (MOI 100:1), F. nucleatum (MOI 100:1) and PMA (5nM). 
Data presented as patient RLU as a percentage of paired control RLU at baseline and the 2-
month review. Box and whisker plots show median, interquartile range, maximum and 
minimum. P-values calculated using one-tailed Wilcoxon.  
 
Figure 3: Plasma hsCRP concentrations for patients and healthy controls at baseline and the 
2-month review (n=19). Box and whisker plots show median, interquartile range, maximum 
and minimum. Outlying value (calculated as >1.5x interquartile range) is shown as a solid 
circle (•) above the y-axis maximum. 
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Figure 4: Scatterplots and regression analyses of unstimulated patient (n=18) and control 
(n=17) neutrophil chemiluminescence and plasma hsCRP concentration (mg/l) at baseline 
and review. P-values corrected to adjust for multiple comparisons.  
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